Author details

Full Name

Uri Tabori

Affiliation

ORCID

Career Start Year

1999

Papers

249

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37401906	MRI-Based End-To-End Pediatric Low-Grade Glioma Segmentation and Classification.	Can Assoc Radiol J	2024
38040059	Proton Therapy Mediates Dose Reductions to Brain Structures Associated With Cognition in Children With Medulloblastoma.	Int J Radiat Oncol Biol Phys	2024
37944912	Pediatric low-grade glioma: State-of-the-art and ongoing challenges.	Neuro Oncol	2024
37823831	Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.	Cancer Discov	2024
37803212	Increased confidence of radiomics facilitating pretherapeutic differentiation of BRAF-altered pediatric low-grade glioma.	Eur Radiol	2024
38079480	Postoperative cerebellar mutism syndrome is an acquired autism-like network disturbance.	Neuro Oncol	2024
37348970	T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma.	AJNR Am J Neuroradiol	2023
36240479	Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.	J Clin Oncol	2023
36341503	Recurrent posterior fossa group A (PFA) ependymoma in a young child with constitutional mismatch repair deficiency (CMMRD).	Neuropathol Appl Neurobiol	2023
37738646	Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation.	Neuro Oncol	2023
37733309	Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations.	N Engl J Med	2023
37555268	Sarcoid-like reaction in a child following prolonged therapeutic exposure to dabrafenib and trametinib for BRAF V600E mutated hypothalamic/chiasmatic glioma.	Pediatr Blood Cancer	2023
37680835	Pakistan National Guidelines for Pediatric High-Grade Gliomas.	Pak J Med Sci	2023
36585449	The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations.	Nat Cancer	2023
36824744	Single-strand mismatch and damage patterns revealed by single-molecule DNA sequencing.		2023
36706870	Insult to Short-Range White Matter Connectivity in Childhood Brain Tumor Survivors.	Int J Radiat Oncol Biol Phys	2023
37126021	Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency.	Clin Cancer Res	2023
37379234	Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.	Neuro Oncol	2023
36932241	Diagnostic classification of childhood cancer using multiscale transcriptomics.	Nat Med	2023
36790526	Using comprehensive genomic and functional analyses for resolving genotype-phenotype mismatches in children with suspected CMMRD in Lebanon: an IRRDC study.	Hum Genet	2023
34749374	Leptomeningeal Dissemination of Low-Grade Neuroepithelial Tumor with FGFR1_TACC1 Fusion with Clinical and Radiographic Response to Pazopanib and Topotecan.	Pediatr Neurosurg	2022
36249063	Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline.	Front Oncol	2022
35592129	Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1.	Front Surg	2022
35484912	Building the ecosystem for pediatric neuro-oncology care in Pakistan: Results of a 7-year long twinning program between Canada and Pakistan.	Pediatr Blood Cancer	2022
35856658	Impact of dedicated pediatric neuro-oncological services in a developing country: A single-institution, Pakistani experience.	Pediatr Blood Cancer	2022
36417526	Widespread hypertranscription in aggressive human cancers.	Sci Adv	2022
36382112	Clinical and molecular features of disseminated pediatric low-grade glioma and glioneuronal tumors: a systematic review and survival analysis.	Neurooncol Adv	2022
36252166	How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?	JCO Glob Oncol	2022
35532657	Germline Biallelic Mismatch Repair Deficiency in Childhood Glioblastoma and Implications for Clinical Management.	Neurology India	2022
36479061	Adolescent and young adult glioma: systematic review of demographic, disease, and treatment influences on survival.	Neurooncol Adv	2022
36529814	THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.		2022
33622763	Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group.	J Med Genet	2022
34992263	Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.	Nat Med	2022
34913598	A novel central nervous system embryonal tumor successfully treated with multi-modal therapy highlights limitation of methylation-based tumor classification.	Pediatr Blood Cancer	2022
34980048	Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma.	BMC Pediatr	2022
35235414	Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study.	JCO Precis Oncol	2022
34529227	Paediatric atypical choroid plexus papilloma: is adjuvant therapy necessary?	J Neurooncol	2021
33741928	The transcriptional landscape of Shh medulloblastoma.	Nat Commun	2021
33535600	Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an -Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report-Usage of Immune Checkpoint Inhibition in CMMRD.	Current Oncology	2021
33574103	Radiomics of Pediatric Low-Grade Gliomas: Toward a Pretherapeutic Differentiation of <i>BRAF-</i>Mutated and <i>BRAF</i>-Fused Tumors.	AJNR Am J Neuroradiol	2021
33945292	Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.	J Clin Oncol	2021
34045740	Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.	Nat Med	2021
33668028	Ventricular size determination and management of ventriculomegaly and hydrocephalus in patients with diffuse intrinsic pontine glioma: an institutional experience.	J Neurosurg	2021
33563663	Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition.	Cancer Discov	2021
33876327	Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.	Acta Neuropathol	2021
33502920	Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.	J Clin Oncol	2021
33259954	An Integrative DNA Sequencing and Methylation Panel to Assess Mismatch Repair Deficiency.	J Mol Diagn	2021
33258245	Re-irradiation with concurrent BRAF and MEK inhibitor therapy.	Pediatr Blood Cancer	2021
33355208	DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells.	Cancer Discov	2021
32681754	Salvage chemotherapy after failure of targeted therapy in a child with BRAF V600E low-grade glioma.	Pediatr Blood Cancer	2021